Your browser doesn't support javascript.
loading
Patients with both CYP2C19 loss-of-function allele and peripheral endothelial dysfunction are significantly correlated with adverse cardiovascular events following coronary stent implantation.
Tabata, Noriaki; Hokimoto, Seiji; Akasaka, Tomonori; Arima, Yuichiro; Sakamoto, Kenji; Yamamoto, Eiichiro; Tsujita, Kenichi; Izumiya, Yasuhiro; Yamamuro, Megumi; Kojima, Sunao; Kaikita, Koichi; Kumagae, Naoki; Morita, Kazunori; Oniki, Kentaro; Nakagawa, Kazuko; Matsui, Kunihiko; Ogawa, Hisao.
Afiliación
  • Tabata N; Department of Cardiovascular Medicine, Graduate School of Medical Sciences, Kumamoto University, Kumamoto City, Japan.
  • Hokimoto S; Department of Cardiovascular Medicine, Graduate School of Medical Sciences, Kumamoto University, Kumamoto City, Japan. Electronic address: shokimot@kumamoto-u.ac.jp.
  • Akasaka T; Department of Cardiovascular Medicine, Graduate School of Medical Sciences, Kumamoto University, Kumamoto City, Japan.
  • Arima Y; Department of Cardiovascular Medicine, Graduate School of Medical Sciences, Kumamoto University, Kumamoto City, Japan.
  • Sakamoto K; Department of Cardiovascular Medicine, Graduate School of Medical Sciences, Kumamoto University, Kumamoto City, Japan.
  • Yamamoto E; Department of Cardiovascular Medicine, Graduate School of Medical Sciences, Kumamoto University, Kumamoto City, Japan.
  • Tsujita K; Department of Cardiovascular Medicine, Graduate School of Medical Sciences, Kumamoto University, Kumamoto City, Japan.
  • Izumiya Y; Department of Cardiovascular Medicine, Graduate School of Medical Sciences, Kumamoto University, Kumamoto City, Japan.
  • Yamamuro M; Department of Cardiovascular Medicine, Graduate School of Medical Sciences, Kumamoto University, Kumamoto City, Japan.
  • Kojima S; Department of Cardiovascular Medicine, Graduate School of Medical Sciences, Kumamoto University, Kumamoto City, Japan.
  • Kaikita K; Department of Cardiovascular Medicine, Graduate School of Medical Sciences, Kumamoto University, Kumamoto City, Japan.
  • Kumagae N; Division of Pharmacology and Therapeutics, Graduate School of Medical and Pharmaceutical Sciences, Kumamoto University, Kumamoto City, Japan.
  • Morita K; Division of Pharmacology and Therapeutics, Graduate School of Medical and Pharmaceutical Sciences, Kumamoto University, Kumamoto City, Japan.
  • Oniki K; Division of Pharmacology and Therapeutics, Graduate School of Medical and Pharmaceutical Sciences, Kumamoto University, Kumamoto City, Japan.
  • Nakagawa K; Division of Pharmacology and Therapeutics, Graduate School of Medical and Pharmaceutical Sciences, Kumamoto University, Kumamoto City, Japan.
  • Matsui K; Department of Community Medicine, Kumamoto University Hospital, Kumamoto City, Japan.
  • Ogawa H; Department of Cardiovascular Medicine, Graduate School of Medical Sciences, Kumamoto University, Kumamoto City, Japan.
J Cardiol ; 67(1): 104-9, 2016 Jan.
Article en En | MEDLINE | ID: mdl-25851472

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Polimorfismo Genético / Endotelio Vascular / Stents / Intervención Coronaria Percutánea / Citocromo P-450 CYP2C19 Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Aged / Female / Humans / Male / Middle aged País/Región como asunto: Asia Idioma: En Revista: J Cardiol Asunto de la revista: CARDIOLOGIA Año: 2016 Tipo del documento: Article País de afiliación: Japón

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Polimorfismo Genético / Endotelio Vascular / Stents / Intervención Coronaria Percutánea / Citocromo P-450 CYP2C19 Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Aged / Female / Humans / Male / Middle aged País/Región como asunto: Asia Idioma: En Revista: J Cardiol Asunto de la revista: CARDIOLOGIA Año: 2016 Tipo del documento: Article País de afiliación: Japón